Adolescents and young adults with preexisting autoimmune disease are more likely to develop type 1 diabetes than those ...

Pregnancy complications such as gestational diabetes mellitus (GDM), preeclampsia, and gestational hypertensive disorders are becoming increasingly ...

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to ...

The company reported its second late-stage study success, this time with a drug that could become a new treatment standard ...

Based on the DESTINY-Breast06 phase III trial results demonstrating statistically significant and clinically meaningful progression-free survival benefit in patients treated with Enhertu vs.

Attendees can take advantage of free health screenings, learn practical tips for diabetes management, and connect directly ...

Your pancreas, crucial for digestion and blood sugar, can signal distress through persistent abdominal pain, unexplained ...

Chemotherapy poses the highest risk for early menopause, particularly in women over 40, while radiation does not impact ...

BBP-418 hit the mark in the phase 3 FORTIFY trial by achieving a significant increase in glycosylated alpha-dystroglycan (αDG), which is impaired in LGMD and causes muscle wasting, initially in the ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the ...

Experts discuss the impact of dose escalation in treating neuroendocrine tumors, highlighting recent trials and collaborative research efforts for improved patient outcomes.